​

Hologic (HOLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HOLX Stock Forecast

Hologic (HOLX) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $77.80, with a high of $79.00 and a low of $76.00. This represents a 3.94% increase from the last price of $74.85.

$70 $73 $76 $79 $82 $85 High: $79 Avg: $77.8 Low: $76 Last Closed Price: $74.85

HOLX Stock Rating

Hologic stock's rating consensus is Hold, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 20 Buy (47.62%), 21 Hold (50.00%), 1 Sell (2.38%), and 0 Strong Sell (0.00%).

Hold
Total 42 1 21 20 Strong Sell Sell Hold Buy Strong Buy

HOLX Price Target Upside V Benchmarks

TypeNameUpside
StockHologic3.94%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks15.15%

Price Target Trends

1M3M12M
# Anlaysts157
Avg Price Target$79.00$77.80$75.57
Last Closing Price$74.85$74.85$74.85
Upside/Downside5.54%3.94%0.96%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-315--18
Nov, 251314--18
Oct, 253511--19
Sep, 254511--20
Aug, 253313--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 21, 2025BNP Paribas$79.00$74.126.58%5.54%
Oct 23, 2025Mizuho Securities$78.00$73.935.51%4.21%
Oct 22, 2025Stephens$76.00$74.012.69%1.54%
Oct 21, 2025Leerink Partners$78.00$74.085.29%4.21%
Oct 07, 2025Vijay KumarEvercore ISI$78.00$67.3415.83%4.21%
Jul 31, 2025Mizuho Securities$75.00$64.9815.42%0.20%
May 05, 2025Tejas SavantMorgan Stanley$65.00$52.7323.27%-13.16%
Nov 05, 2024Anthony PetroneMizuho Securities$87.00$78.8010.41%16.23%
Oct 04, 2024Anthony PetroneMizuho Securities$90.00$79.6313.02%20.24%
Oct 01, 2024Patrick DonnellyCitigroup$85.00$81.464.35%13.56%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 21, 2025Exane BNP ParibasNeutraldowngrade
Nov 04, 2025NeedhamHoldHoldhold
Oct 21, 2025William BlairCautiousMarket Performdowngrade
Oct 07, 2025Evercore ISIPositiveOutperformupgrade
Oct 14, 2024NeedhamBuyBuyhold
Oct 14, 2024William BlairCautiousCautioushold
Oct 04, 2024StephensSector PerformSector Performhold
Oct 01, 2024Evercore ISIPositivePositivehold
Oct 01, 2024CitigroupBuyNeutraldowngrade
Sep 17, 2024NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

$1 $2 $3 $4 $5 $6 $7 $8 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$7.28$5.18$1.85$3.35$2.50----
Avg Forecast$7.80$3.49$3.91$4.08$4.26$4.68$5.17$5.67$5.90
High Forecast$8.00$4.18$3.95$4.09$4.29$4.77$5.59$5.74$5.97
Low Forecast$7.60$2.79$3.78$3.96$4.23$4.57$4.30$5.49$5.71
Surprise %-6.67%48.42%-52.69%-17.89%-41.31%----

Revenue Forecast

$4B $4B $5B $5B $6B $6B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$5.63B$4.86B$4.03B$4.03B$4.10B----
Avg Forecast$5.35B$4.51B$4.03B$4.02B$4.16B$4.40B$4.67B$5.00B$5.15B
High Forecast$5.45B$5.41B$4.06B$4.06B$4.17B$4.44B$4.68B$5.04B$5.20B
Low Forecast$5.24B$3.61B$4.02B$3.92B$4.15B$4.36B$4.66B$4.88B$5.03B
Surprise %5.33%7.82%0.13%0.27%-1.49%----

Net Income Forecast

$0 $400M $800M $1B $2B $2B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$1.87B$1.30B$456.00M$789.50M$565.70M----
Avg Forecast$1.46B$1.16B$515.10M$956.11M$1.01B$1.11B$1.17B$1.35B$1.40B
High Forecast$1.76B$1.39B$618.12M$972.57M$1.02B$1.13B$1.33B$1.36B$1.42B
Low Forecast$1.17B$925.83M$412.08M$939.64M$1.01B$1.09B$1.02B$1.31B$1.36B
Surprise %27.81%12.51%-11.47%-17.43%-44.11%----

HOLX Forecast FAQ

Is Hologic stock a buy?

Hologic stock has a consensus rating of Hold, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 20 Buy, 21 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Hologic is a neutral investment for most analysts.

What is Hologic's price target?

Hologic's price target, set by 42 Wall Street analysts, averages $77.8 over the next 12 months. The price target range spans from $76 at the low end to $79 at the high end, suggesting a potential 3.94% change from the previous closing price of $74.85.

How does Hologic stock forecast compare to its benchmarks?

Hologic's stock forecast shows a 3.94% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (15.15%).

What is the breakdown of analyst ratings for Hologic over the past three months?

  • December 2025: 0% Strong Buy, 16.67% Buy, 83.33% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 5.56% Strong Buy, 16.67% Buy, 77.78% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 15.79% Strong Buy, 26.32% Buy, 57.89% Hold, 0% Sell, 0% Strong Sell.

What is Hologic’s EPS forecast?

Hologic's average annual EPS forecast for its fiscal year ending in September 2026 is $4.68, marking a 87.20% increase from the reported $2.5 in 2025. Estimates for the following years are $5.17 in 2027, $5.67 in 2028, and $5.9 in 2029.

What is Hologic’s revenue forecast?

Hologic's average annual revenue forecast for its fiscal year ending in September 2026 is $4.4B, reflecting a 7.36% increase from the reported $4.1B in 2025. The forecast for 2027 is $4.67B, followed by $5B for 2028, and $5.15B for 2029.

What is Hologic’s net income forecast?

Hologic's net income forecast for the fiscal year ending in September 2026 stands at $1.11B, representing an 96.18% increase from the reported $565.7M in 2025. Projections indicate $1.17B in 2027, $1.35B in 2028, and $1.4B in 2029.